The activation of NLRP3 in endothelial cells (ECs) represents a key event leading to endothelial damage [227], and its impact on atherosclerosis is primarily mediated by the effector cytokine IL-1β [237, 238]. Here, NLRP3 is linked to atherosclerosis.